127 related articles for article (PubMed ID: 18057543)
1. Genetically engineered rat models for breast cancer.
Smits BM; Cotroneo MS; Haag JD; Gould MN
Breast Dis; 2007; 28():53-61. PubMed ID: 18057543
[TBL] [Abstract][Full Text] [Related]
2. Special considerations in mouse models of breast cancer.
Borowsky A
Breast Dis; 2007; 28():29-38. PubMed ID: 18057541
[No Abstract] [Full Text] [Related]
3. BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.
Diaz-Cruz ES; Cabrera MC; Nakles R; Rutstein BH; Furth PA
Breast Dis; 2010; 32(1-2):85-97. PubMed ID: 21778574
[TBL] [Abstract][Full Text] [Related]
4. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
[TBL] [Abstract][Full Text] [Related]
5. BRCA1, C-erbB-2, and H-ras gene expressions in young women with breast cancer. An immunohistochemical study.
Ozer E; Sis B; Ozen E; Sakizli M; Canda T; Sarioğlu S
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):12-8. PubMed ID: 10937043
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
[TBL] [Abstract][Full Text] [Related]
7. The genetic components of susceptibility to breast cancer in the rat.
Shepel LA; Gould MN
Prog Exp Tumor Res; 1999; 35():158-69. PubMed ID: 10377759
[TBL] [Abstract][Full Text] [Related]
8. Preclinical mouse models for BRCA1-associated breast cancer.
Drost RM; Jonkers J
Br J Cancer; 2009 Nov; 101(10):1651-7. PubMed ID: 19904273
[TBL] [Abstract][Full Text] [Related]
9. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
10. Specific protection against breast cancers by cyclin D1 ablation.
Yu Q; Geng Y; Sicinski P
Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
[TBL] [Abstract][Full Text] [Related]
11. Characterizing a rat Brca2 knockout model.
Cotroneo MS; Haag JD; Zan Y; Lopez CC; Thuwajit P; Petukhova GV; Camerini-Otero RD; Gendron-Fitzpatrick A; Griep AE; Murphy CJ; Dubielzig RR; Gould MN
Oncogene; 2007 Mar; 26(11):1626-35. PubMed ID: 16964288
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.
Andrechek ER; Muller WJ
Breast Cancer Res; 2000; 2(3):211-6. PubMed ID: 11250712
[TBL] [Abstract][Full Text] [Related]
13. The reciprocal dance between cancer and development.
Chodosh LA
N Engl J Med; 2002 Jul; 347(2):134-6. PubMed ID: 12110743
[No Abstract] [Full Text] [Related]
14. Studying drug resistance using genetically engineered mouse models for breast cancer.
Rottenberg S; Pajic M; Jonkers J
Methods Mol Biol; 2010; 596():33-45. PubMed ID: 19949919
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting and enhanced cytotoxicity to HER2-overexpressing tumors by immunoapoptotin-armored mesenchymal stem cells.
Cai Y; Xi Y; Cao Z; Xiang G; Ni Q; Zhang R; Chang J; Du X; Yang A; Yan B; Zhao J
Cancer Lett; 2016 Oct; 381(1):104-12. PubMed ID: 27473824
[TBL] [Abstract][Full Text] [Related]
16. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
[TBL] [Abstract][Full Text] [Related]
17. ErbB2 activation and signal transduction in normal and malignant mammary cells.
Hynes NE
J Mammary Gland Biol Neoplasia; 1996 Apr; 1(2):199-206. PubMed ID: 10887493
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular aspects of the multistage progression of mammary carcinogenesis in humans and rats.
Gould MN
Semin Cancer Biol; 1993 Jun; 4(3):161-9. PubMed ID: 8318692
[TBL] [Abstract][Full Text] [Related]
19. Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells.
Ciardiello F; Gottardis M; Basolo F; Pepe S; Normanno N; Dickson RB; Bianco AR; Salomon DS
Mol Carcinog; 1992; 6(1):43-52. PubMed ID: 1354442
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer genes: therapeutic strategies.
Holt JT
Ann N Y Acad Sci; 1997 Dec; 833():34-41. PubMed ID: 9616738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
